Anest. intenziv. Med. 2008;19(4):210-217

Antimicrobial protection options in central venous catheters - OverviewIntesive Care Medicine - Review Article

Křikava Ivo*, Ševčík Pavel
Klinika anesteziologie, resuscitace a intenzivní medicíny FN Brno a LF MU Brno

Central venous catheters (CVC) take indispensable place in caring for critically ill patients. Catheter-related infections increase morbidity and mortality. In the article basic CVC protection methods are mentioned with accent on overview of catheters available on the market. Overviews of meta-analyses and several methodological flaws of recent studies are also referred. Meta-analyses showed that anti-infective CVCs reduce the risk of catheter-related blood stream infections, but their routinely use is still not recommended. However, the use of anti-infective CVCs should be considered, when background rates of catheter-related infections are high.

Keywords: central venous catheter; catheter-related infections; impregnated catheter; coated catheter; chlorhexidine; silver sulfadiazine; minocycline; rifampicin

Received: May 12, 2008; Accepted: June 12, 2008; Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Křikava I, Ševčík P. Antimicrobial protection options in central venous catheters - Overview. Anest. intenziv. Med. 2008;19(4):210-217.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Edwards et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006. Dostupné na: http://www.cdc.gov/ncidod/dhqp/nhsn_documents.html.
    2. Gastmeier, P., Zuschneid, I., Geffers, C. Antimicrobially impregnated catheters: An overview of randomized controlled trials. Journal of Vascular Access, 2003, 4, 3, p. 102-110.
    3. Horan, T. C., Gaynes, R. Surveillance of nosocomial infections. In Mayhall, C. G., ed. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott Williams & Wilkins, 2004, p.1659-1702.
    4. Černý, V. et al. Sepse v intenzivní péči. 2. vyd., 2005, p. 28-29.
    5. Morales, M. et al. Biofilm: the microbial "bunker" for intravascular catheter-related infection. Support Care Cancer, 2004, 12, p. 701-707. Go to original source... Go to PubMed...
    6. Růžička, F. Biofilm a jeho význam. In Kurz antibiotické terapie. Praha, 2005.
    7. Modak, S. M., Sampath, L. Development and evaluation of a new polyurethane central venous antisepstic catheter. Complications Surg., 1992, 11, p. 23-29.
    8. Richards, B. et al. Effect of central venous catheter type on infections: a prospective clinical trial. The Journal of Hospital Infection, 2003, 54, 1, p. 10-17. Go to original source... Go to PubMed...
    9. van Vliet, J. et al. A comparison between two types of central venous catheters in the prevention of catheter-related infections: The importance of performing all the relevant cultures. Clinical Intensive Care, 2001, 12, 3, p. 135-140. Go to original source...
    10. Tennenberg, S. et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Archives of Surgery, 1997, 132, 12, p. 1348-1351. Go to original source... Go to PubMed...
    11. Logghe, C. et al. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. The Journal of Hospital Infection, 1997, 37, 2, p. 145-156. Go to original source... Go to PubMed...
    12. Ciresi, D. L. et al. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. The American Surgeon, 1996, 62, 8, p. 641-646. Go to PubMed...
    13. Sheng, W. H. et al. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagnostic Microbiology and Infectious Disease, 2000, 38, 1, p. 1-5. Go to original source... Go to PubMed...
    14. Dunser, M. W. et al. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesthesia and Analgesia, 2005, 101, 6, p. 1778-1784. Go to original source... Go to PubMed...
    15. Maki, D. G. et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Annals of Internal Medicine, 1997, 127, 4, p. 257-266. Go to original source... Go to PubMed...
    16. Brun-Buisson, C. et al. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Medicine, 2004, 30, 5, p. 837-843. Go to original source... Go to PubMed...
    17. Rupp, M. E. et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Annals of Internal Medicine, 2005, 143, 8, p. 570-580. Go to original source... Go to PubMed...
    18. Ostendorf, T. et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients - A double-blind, randomised, prospective, controlled trial. Supportive Care in Cancer, 2005, 13, 12, p. 993-1000. Go to original source... Go to PubMed...
    19. Stephens, R. et al. Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter. British Journal of Anaesthesia, 2001, 87, 2, p. 306-308. Go to original source... Go to PubMed...
    20. Raad, I. et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrobial Agents and Chemotherapy, 1995, 39, 11, p. 2397-2400. Go to original source... Go to PubMed...
    21. Leon, C. et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Medicine, 2004, 30, 10, p. 1891-1899. Go to original source... Go to PubMed...
    22. Darouiche, R. O. et al. A comparison of two antimicrobial-impregnated central venous catheters. New England Journal of Medicine, 1999, 340, 1, p. 1-8. Go to original source... Go to PubMed...
    23. Fraenkel, D. et al. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Critical Care Medicine, 2006, 34, 3, p. 668-675. Go to original source... Go to PubMed...
    24. Falagas, M. E. et al. Rifampicin-impregnated central venous catheters: A meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy, 2007, 59, 3, p. 359-369. Go to original source... Go to PubMed...
    25. Niël-Weise, B. S., Stijnen, T., van den Broek, P. J. Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. Intensive Care Med., 2007, 12, 33, p. 2058-2068. Go to original source... Go to PubMed...
    26. Guggenbichler, J.-P. et al. A New Technology of Microdispersed Silver in Polyurethane Induces Antimicrobial Activity in Central Venous Catheters. Infection, 1999, 27, Suppl. 1, p. S16-S23. Go to original source... Go to PubMed...
    27. Bechert, T. et al. The Erlanger Silver Catheter: In Vitro Results for Antimicrobial Activity. Infection, 1999, 27, Suppl. 1, p. S24-S29. Go to original source... Go to PubMed...
    28. Boswald, M. et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection, 1999, 27, Suppl. 1, p. S56-60. Go to original source... Go to PubMed...
    29. Goldschmidt, H. et al. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralblatt für Bakteriologie : International Journal of Medical Microbiology, 1995, 283, 2, p. 215-223. Go to original source... Go to PubMed...
    30. Furno, F. et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J. Antimicrob. Chemother., 2004, 54, p. 1019-1024. Go to original source... Go to PubMed...
    31. Moretti, E. W. et al. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. The Journal of Hospital Infection, 2005, 61, 2, p. 139-145. Go to original source... Go to PubMed...
    32. Yorganci, K. et al. In Vitro Evaluation of the Antibacterial Activity of Three Different Central Venous Catheters Against Gram-Positive Bacteria. Eur. J. Clin. Microbiol. Infect. Dis., 2002, 21, p. 379-384. Go to original source... Go to PubMed...
    33. Ranucci, M. et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit. Care Med., 2003, 31, 1, p. 52-59. Go to original source... Go to PubMed...
    34. Kalfon, P. et al. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit. Care Med., 2007, 35, 4, p. 1032-1039. Go to original source... Go to PubMed...
    35. Walz, J. M. et al. A multicenter randomized controlled clinical trial comparing central venous catheters impregnated with either 5-Fluorouracil or chlorhexidine/silver sulfadiazine in preventing catheter colonization. 28th International Symposium on Intensive Care and Emergency Medicine, Brussels, March 18-21, 2008. Go to original source...
    36. Scott, A. et al. Do Antimicrobial-Impregnated Central Venous Catheters Prevent Catheter-Related Bloodstream Infection? Clinical Infectious Diseases, 2003, 37, p. 65-72. Go to original source... Go to PubMed...
    37. Crnich, C. J., Maki, D. G. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater. Clin. Infect. Diseases, 2004, 38, 9, p. 1287-1292. Go to original source... Go to PubMed...
    38. Carrasco, M. N. et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Medicine, 2004, 30, 4, p. 633-638. Go to original source... Go to PubMed...
    39. Collin, G. R. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest, 1999, 115, 6, p. 1632-1640. Go to original source... Go to PubMed...
    40. Cicalini, S., Palmieri, F., Petrosillo, N. Clinical review: New technologies for prevention of intravascular catheter-related infections. Critical Care, 2004, 8, 3, p. 157-162. Go to original source... Go to PubMed...
    41. Eggimann, P. Prevention of intravascular catheter infection. Current Opinion in Infectious Diseases, 2007, 20, 4, p. 360-369. Go to original source... Go to PubMed...
    42. O'Grady, N. et al. Guidelines for the prevention of intravascular catheter-related infections. Infection Control and Hospital Epidemiology, 2002, 23, 12, p. 759-769. Go to original source...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.